DARMSTADT, Germany, March 20, 2018 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany (XETRA: MRK, OTC Pink: MKKGY), a leading science and technology company, today announced that it will present at the dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on 22nd March 2018. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors.
DATE: |
March 22nd, 2018 |
TIME: |
11.30am ET |
LINK: |
This will be a live, interactive online event where investors are invited to ask international companies their questions in real-time and to download a company's information in their "virtual trade booth" in the Exhibits section. If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
Participation is free of charge.
It is recommended that investors pre-register to save time and receive event updates.
Recent Company Highlights
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck KGaA, Darmstadt, Germany, generated sales of € 15.3 billion in 66 countries.
SOURCE Merck KGaA